Analona Therapeutics
Pre-clinicalFounded in 2024, based on our top tier solid tumor research, which has identified a range of novel targets and mechanisms of action.
Founded
2024
Focus
AntibodiesBiologics
About
Founded in 2024, based on our top tier solid tumor research, which has identified a range of novel targets and mechanisms of action.
Funding History
2Total raised: $15.5M
Series A$12MNovo HoldingsMar 15, 2023
Seed$3.5MNovo SeedsSep 15, 2021
Company Info
TypePrivate
Founded2024
LocationCopenhagen, Denmark
StagePre-clinical
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile